August 26, 2026

Business

From $25B to $55B: Moderna’s Melanoma Math

Aug 26, 2026

The Phase 3 win validated the platform. Now the harder work begins: manufacturing every dose from scratch.

Newsletters

Three Stocks for a World Ditching the Dollar

Aug 26, 2026

August 25, 2026 De-dollarization is accelerating faster than the calendar suggests. The dollar’s reserve share...

Economy

UP-NS Decision Pushed to H2 2027

Aug 26, 2026

STB calendar extends arb risk into 2027, with Nov. 18 as the first must-watch date.

Sign up for our free Rising Star Stocks Newsletter!

Discover new market trends and ideas directly to your inbox.

✅ You're in! Check your inbox soon.

By submitting your email address, you'll receive a free subscription to Rising Star Stocks newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.

August 26, 2026

From $25B to $55B: Moderna’s Melanoma Math

Three Stocks for a World Ditching the Dollar

UP-NS Decision Pushed to H2 2027

Archives

Categories